Efzofitimod for the Treatment of Pulmonary Sarcoidosis
Daniel A. Culver(Cleveland Clinic), Robert P. Baughman(University of Cincinnati), Joseph B. Barney(University of Alabama at Birmingham), Shambhu Aryal(Inova Fairfax Hospital), Connie C. W. Hsia(The University of Texas Southwestern Medical Center), Lucian T. Marts(Emory University), Nelson Kinnersley(University of Rochester), Gennyne Walker(aTyr Pharma (United States)), Sanjay Shukla(aTyr Pharma (United States)), Lisa A. Maier(National Jewish Health), W. Ennis James(Medical University of South Carolina), Nadera Sweiss(University of Illinois Chicago), Peter H. S. Sporn(Northwestern University), Ogugua Ndili(East Carolina University)
Cited by 57
Related Papers
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell Function
|Cell stem cell|2014|929
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579